European drug regulator Oxford University and pharma giant AstraZeneca are set to begin a quick review of potential vaccines for coronoviruses. This indicates that this may be the first approved vaccine in the region. US media Bloomberg reported this.
The European Pharmaceutical Agency (EMA) has announced that it is launching a so-called ‘rolling review’. Such measures are usually taken in health emergencies. Through this, the regulatory body reviews the data of the clinical trial, regardless of whether a vaccine or drug is in the process of being invented. This speeds up the approval process.
According to a Bloomberg report, this is a major step forward for the Oxford vaccine after a volunteer who took part in a clinical trial last month fell ill.
According to the EMA, the review is being initiated based on preliminary information. However, this does not mean that any conclusions have been reached about the safety and effectiveness of the vaccine.
A spokesperson for AstraZeneca said that they welcomed the decision and would provide the necessary information to the EMA as soon as available.
The worldwide death toll in Corona has exceeded one million. Corona infection is on the rise again across Europe.